Adient (ADNT)
(Delayed Data from NYSE)
$28.86 USD
-0.26 (-0.89%)
Updated May 20, 2024 04:00 PM ET
After-Market: $28.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$28.86 USD
-0.26 (-0.89%)
Updated May 20, 2024 04:00 PM ET
After-Market: $28.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Zacks News
Adient (ADNT) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 500% and 3.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Adient (ADNT) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beware of These 2 Auto Equipment Suppliers Amid Industry Woes
by Rimmi Singhi
With the automotive equipment industry struggling with supply chain disruptions and cost woes, we advise you to stay away from stocks like Autoliv (ALV) and Adient (ADNT) to prevent losses.
Adient (ADNT) Q2 Earnings Miss, Sales Beat, '22 View Trimmed
by Zacks Equity Research
Adient (ADNT) now envisions fiscal 2022 revenues of $14.2 billion, down from the prior guidance of $14.8 billion.
Adient (ADNT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -750% and 2.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Adient (ADNT) Q2 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allison Transmission (ALSN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Allison Transmission (ALSN) delivered earnings and revenue surprises of 12.07% and 5.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 12th
by Zacks Equity Research
ADNT, FRGI, and COWN have been added to the Zacks Rank #5 (Strong Sell) List on April 12, 2022.
BorgWarner (BWA) Beats on Q4 Earnings, Announces Buyout Deal
by Zacks Equity Research
BorgWarner (BWA) beats Q4 earnings and revenue estimates. Meanwhile, it inks a deal to buy Santroll's light vehicle eMotor business to strengthen its position in electric propulsion systems.
The Zacks Analyst Blog Highlights: Ford, General Motors, Cummins, Adient and Meritor
by Zacks Equity Research
Ford, General Motors, Cummins, Adient and Meritor are included in this analyst blog.
Auto Roundup: Quarterly Earnings in Focus; GM Beats, F Misses & Other Updates
by Rimmi Singhi
While General Motors' (GM) Q4 EPS beat estimates, it dips 30% y/y. Its close peer Ford's (F) Q4 earnings miss mark and decline 23.5% on a year-over-year basis.
Adient (ADNT) Incurs Q1 Loss, Surpasses Sales Estimates
by Zacks Equity Research
Adient (ADNT) incurs a loss in fiscal Q1 due to downsized EBITDA across segments brought about by the global market headwinds.
Adient (ADNT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -575% and 2.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Wabash National (WNC) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Wabash (WNC) delivered earnings and revenue surprises of -41.67% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gentex (GNTX) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of 2.94% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Westport Fuel, Adient, Lithia, Sonic Automotive, and Daimler
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Westport Fuel, Adient, Lithia, Sonic Automotive, and Daimler
Auto Stock Roundup: WPRT & ADNT Quarterly Results, DDAIF Twin Deals & More
by Rimmi Singhi
While Westport (WPRT) and Adient (ADNT) deliver quarterly losses, Daimler (DDAIF) collaborates with Total Energies and Visa.
Adient's (ADNT) Q4 Loss Narrower Than Expected, Sales Miss
by Zacks Equity Research
Adient (ADNT) expects fiscal 2022 revenues of $14.8 billion, higher than $13.7 billion recorded in fiscal 2021.
Key Factors to Note Ahead of Hyliion's (HYLN) Q3 Earnings
by Zacks Equity Research
Rising R&D and SG&A expenses are likely to have dented Hyliion's (HYLN) Q3 performance.
Lear's (LEA) Q3 Earnings Miss Estimates, 2021 View Tepid
by Zacks Equity Research
Lear (LEA) forecasts full-year 2021 sales in the band of $18.8-$19.2 billion, down from the previous guided range of $20.3-$21.1 billion.
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Factors to Note Ahead of Magna's (MGA) Q3 Earnings
by Zacks Equity Research
Declining revenues across all segments and rising costs are likely to have dented Magna's (MGA) Q3 performance.
Oshkosh (OSK) Beats Q4 Earnings Estimates, Hikes Dividend
by Zacks Equity Research
Oshkosh (OSK) delivers a comprehensive fiscal Q4 beat and announces a 12% dividend hike.
Allison (ALSN) Q3 Earnings Match Estimates, Sales Beat
by Zacks Equity Research
Amid persistent supply chain disruptions, Allison (ALSN) trims its 2021 guidance. It now projects net sales in the band of $2,325-$2,400 million versus the prior estimate of $2,325-$2,475 million.